West Hills, CA, United States of America

David Dunleavy

USPTO Granted Patents = 9 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by David Dunleavy in Diabetes Therapy

Introduction

David Dunleavy, based in West Hills, CA, is a prominent inventor in the field of diabetes therapy. He holds nine patents that contribute to innovative solutions for managing diabetes through technology. His work focuses on enhancing therapy delivery systems and improving patient safety during vehicle operation.

Latest Patents

Among David's latest inventions, one notable patent involves a prediction-based system for delivering or guiding therapy for diabetes. This system is designed to utilize processors that respond to predictions of meal events. By providing instructions to an insulin delivery device, it can administer a partial therapy dosage before a meal and the remaining dosage during the meal based on the patient's movement characteristics.

Another significant patent addresses the need for adjusting diabetes alerts and therapy based on gesture detection while operating a vehicle. The system leverages processors that can detect whether a patient with diabetes is driving. Upon detecting vehicle operation, the patient device can output alerts according to a pre-determined driving alert protocol, and an insulin pump can adjust its operation according to a driving therapy protocol.

Career Highlights

David Dunleavy is employed at Medtronic Minimed, Inc., where he has made considerable contributions to the advancement of diabetes management technologies. His innovative work has not only led to significant patents but has also aided in enhancing the quality of life for patients with diabetes.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Louis J Lintereur and Patrick E Weydt. Their combined skills and expertise have fostered a collaborative environment that encourages cutting-edge innovations in insulin delivery and patient management systems.

Conclusion

David Dunleavy's contributions to diabetes therapy represent a significant advancement in the field of medical technology. His innovative patents and collaborations demonstrate a commitment to improving patient care and managing diabetes more effectively. With continued dedication, he is likely to remain at the forefront of innovations in healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…